Published in Carcinogenesis on March 01, 1992
Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ Health Perspect (2000) 1.27
Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect (1993) 0.87
"Dead Cells Talking": The Silent Form of Cell Death Is Not so Quiet. Biochem Res Int (2012) 0.79
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell (2001) 2.89
Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest (1987) 1.82
Value of histochemical stains for copper in the diagnosis of Wilson's disease. Histopathology (1998) 1.48
Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans. Eur J Clin Invest (1999) 1.47
Massive hepatic haemosiderosis in Wilson's disease. Histopathology (2000) 1.39
Would a morphomolecular approach help in defining pseudosarcomatous myofibroblastic proliferations? A study of a heart polypoid lesion. J Clin Pathol (2008) 1.39
Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J Hepatol (1999) 1.28
Liver tumour promotion by chemicals: models and mechanisms. Cancer Surv (1986) 1.25
Initiation of chemical carcinogenesis requires cell proliferation. Nature (1978) 1.25
Association between v-Src and protein kinase C delta in v-Src-transformed fibroblasts. J Biol Chem (1997) 1.22
Effect of dietary tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. J Biol Chem (1968) 1.19
Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by diethylnitrosamine. Cancer Res (1981) 1.17
Cycloheximide, an inhibitor of peptide chain termination or release in liver in vivo and in vitro. Biochem Biophys Res Commun (1971) 1.17
The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. J Clin Endocrinol Metab (2006) 1.17
Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res (1981) 1.15
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene (2012) 1.11
A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci U S A (2001) 1.11
Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest (1985) 1.09
Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study. Am J Pathol (1984) 1.09
Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Pathol (1991) 1.09
High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol (2005) 1.08
Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis (2007) 1.08
Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP). Cell Death Differ (1999) 1.08
Rapid induction of apoptosis in rat liver by cycloheximide. Am J Pathol (1992) 1.07
Nonrandom nature of in vivo methylation of dimethylnitrosamine and the subsequent removal of methylated products from rat liver chromatin DNA. Cancer Res (1976) 1.06
In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene (1998) 1.02
A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res (1985) 1.02
5-azacytidine potentiates initiation induced by carcinogens in rat liver. Carcinogenesis (1985) 1.01
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J (2001) 1.00
Induction of pancreatic acinar cell proliferation by thyroid hormone. J Endocrinol (2005) 1.00
Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol (1989) 0.98
Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis (1995) 0.97
Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency. J Med Genet (2005) 0.97
The influence of tryptophan on hepatic polyribosomes and protein synthesis in fasted mice. Biochem Biophys Res Commun (1967) 0.97
Non-random nature of in vivo interaction of 3H-N-hydroxy-2-acetylaminofluorene and its subsequent removal from rat liver chromatin-DNA. Chem Biol Interact (1976) 0.97
Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis (1995) 0.97
Does iron concentration in a liver needle biopsy accurately reflect hepatic iron burden in beta-thalassemia? Clin Chem (2000) 0.97
Cell proliferation and promotion of rat liver carcinogenesis: different effect of hepatic regeneration and mitogen induced hyperplasia on the development of enzyme-altered foci. Carcinogenesis (1990) 0.96
Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res (1987) 0.96
The role of immunohistochemistry in the diagnosis of hyalinizing clear cell carcinoma of the minor salivary gland: a case report. Eur J Histochem (2008) 0.95
Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis. Environ Health Perspect (1983) 0.94
Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene. Am J Pathol (2000) 0.93
An electron microscopic study of apoptosis induced by cycloheximide in rat liver. Liver (1994) 0.93
Sequential alterations in growth control and cell dynamics of rat hepatocytes in early precancerous steps in hepatocarcinogenesis. Cancer Res (1986) 0.93
Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas. Cancer Res (2000) 0.93
Endometrial polyps with predominant stromal component are characterized by a t(6;14)(p21;q24) translocation. Cancer Res (1995) 0.92
Apoptosis: a general comment. FASEB J (1991) 0.91
Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration. Hepatology (1993) 0.91
Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C. J Pediatr (1994) 0.90
Thymosin beta 4 expression in normal skin, colon mucosa and in tumor infiltrating mast cells. Eur J Histochem (2010) 0.89
Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol (1983) 0.89
Synthesis and fragmentation of DNA in phytohaemagglutinin-stimulated human peripheral blood lymphocytes. Immunol Commun (1973) 0.89
Studies on carcinogen chromatin--DNA interaction: inhibition of N-methyl-N-nitrosourea-induced methylation of chromatin--DNA by spermine and distamycin A. Biochemistry (1978) 0.89
Expression pattern of thymosin beta 4 in the adult human liver. Eur J Histochem (2011) 0.89
Identification of PiZ gene products in liver tissue by a monoclonal antibody specific for the Z mutant of alpha 1-antitrypsin. J Hepatol (1991) 0.88
Immunohistochemical and genetic characterization of the M Cagliari alpha-1-antitrypsin molecule (M-like alpha-1-antitrypsin deficiency). Lab Invest (1994) 0.88
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA. Carcinogenesis (1990) 0.87
Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect (1993) 0.87
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ Health Perspect (1993) 0.87
Induction of hepatocyte proliferation by retinoic acid. Carcinogenesis (2004) 0.87
Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma. Eur J Histochem (2014) 0.86
Dietary orotic acid, a new selective growth stimulus for carcinogen altered hepatocytes in rat. Cancer Lett (1982) 0.86
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis (1989) 0.84
Characterization of multipotent cells from human adult hair follicles. Toxicol In Vitro (2006) 0.84
Dietary orotic acid enhances the incidence of gamma-glutamyltransferase positive foci in rat liver induced by chemical carcinogens. Carcinogenesis (1983) 0.84
[CK20 expression in the gastrointestinal tract of the embryo and fetus]. Pathologica (2001) 0.84
Chemical carcinogenesis: the liver as a model. Pathol Immunopathol Res (1986) 0.84
Evidence for a direct interaction of L-ascorbate with rat liver DNA. Biochim Biophys Acta (1981) 0.84
Uterine leiomyoma cytogenetics. II. Report of forty cases. Cancer Genet Cytogenet (1991) 0.83
Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract. Eur J Histochem (2010) 0.83
Uneven copper distribution in the human newborn liver. Hepatology (1987) 0.83
The usefulness of c-Kit in the immunohistochemical assessment of melanocytic lesions. Eur J Histochem (2011) 0.83
Cell proliferation in rat kidney induced by 1,2-dibromoethane. Toxicol Lett (1987) 0.83